US 6,982,277 B2
P53 inhibitors and therapeutic use of the same
Andrei V. Gudkov, Glencoe, Ill. (US); Pavel G. Komarov, Oak Park, Ill. (US); and Elena A. Komarova, Oak Park, Ill. (US)
Assigned to The Board of Trutees of the University of Illinois, Urbana, Ill. (US)
Filed on Jan. 24, 2003, as Appl. No. 10/350,560.
Application 10/350560 is a division of application No. 09/493527, filed on Jan. 28, 2000, granted, now 6,593,353.
Claims priority of provisional application 60/117881, filed on Jan. 29, 1999.
Prior Publication US 2003/0144331 A1, Jul. 31, 2003
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 31/425 (2006.01)
U.S. Cl. 514—367 5 Claims
 
1. A method of reducing hair loss associated with a cancer therapy comprising administering a therapeutically effective dose of a reversible p53 inhibitor to a mammal in need thereof in conjunction with the cancer therapy.